Search
Abstract.
Online sales of pharmaceuticals are a rapidly growing phenomenon. Yet despite the dangers of purchasing drugs over the Internet, sales continue to escalate. These dangers include patient harm from fake or tainted drugs, lack of clinical oversight, and financial loss. Patients, and in particular vulnerable groups such as seniors and minorities, purchase drugs online either naïvely or because they lack the ability to access medications from other sources due to price considerations. Unfortunately, high risk online drug sources dominate the Internet, and virtually no accountability exists to ensure safety of purchased products.
Importantly, search engines such as Google, Yahoo, and MSN, although purportedly requiring “verification” of Internet drug sellers using PharmacyChecker.com requirements, actually allow and profit from illicit drug sales from unverified websites. These search engines are not held accountable for facilitating clearly illegal activities. Both website drug seller anonymity and unethical physicians approving or writing prescriptions without seeing the patient contribute to rampant illegal online drug sales. Efforts in this country and around the world to stem the tide of these sales have had extremely limited effectiveness. Unfortunately, current congressional proposals are fractionated and do not address the key issues of demand by vulnerable patient populations, search engine accountability, and the ease with which financial transactions can be consummated to promote illegal online sales.
To deal with the social scourge of illicit online drug sales, this article proposes a comprehensive statutory solution that creates a nocost/low-cost national Drug Access Program to break the chain of demand from vulnerable patient populations and illicit online sellers, makes all Internet drug sales illegal unless the Internet pharmacy is licensed through a national Internet pharmacy licensing program, prohibits financial transactions for illegal online drug sales, and establishes criminal penalties for all parties—including websites, search engines, and health care providers— who engage in and facilitate this harmful activity.
Read MoreOn Tuesday December 7, the Bangladeshi Rapid Action Battalion shut down and sealed two counterfeit medications factory in Dhaka, Bangladesh.
Read MoreOn December 7, the State Food and Drug Administration announced that six defendants were found guilty of selling fake medicines and sentenced to 1 to 3 years imprisonment with fines.
Read MorePSM India Announcement in Mumbaiby PSM India via Flickr.
Read MoreThe Partnership for Safe Medicines (PSM) India, a group of nonprofit organizations and individuals dedicated to protecting consumers from spurious drugs, today announced the availability of a 24-hour helpline (1800-11-4424) to assist, educate and empower consumers across India.
Read MoreSouthern Sudan is revamping its pharmaceutical supply chain, building laboratories and monitoring units to prevent smuggling of fake drugs as it recovers from 21 years of civil war. According to Manyang Agoth, Director-General of the Pharmaceutical Services at the Southern Sudan’s Ministry of Health, the drug supply system collapsed during the civil war as “then-existing facilities – including fully-equipped laboratories…
Read MoreIn northwest Cambodia’s Pailin province, on the border with Thailand, counterfeit drug surveillance has taken on a personal meaning as local malaria has evolved artemisinin resistance by sending police door-to-door to local pharmacies and confiscating counterfeit anti-malarials as well as spreading the word of free treatment.
Read MoreThe Philippine Department of Health (DOH) issued a warning to the public against fake drugs and vitamin supplements that they believe have proliferated the country’s markets. Counterfeit drugs may contain harmful ingredients or lack the necessary ingredients and have low concentration of active ingredients that may impact efficacy, said DOH Regional Director Myrna Cabotaje in a government press release. She…
Read MoreRussian citizen Oleg Nikolaenko used Mega-D, a spam botnet, to make approximately $500,000 in six months in 2007 while infecting a network of computers to use to send out junk emails hawking fake drugs. Given his access to money, and lack of ties in the U.S. he’s been denied bail by a Federal Judge. Nikolaenko plead not guilty in federal…
Read MoreIn November 2009, the Ministry of Health and Family Welfare notified a new reward scheme for whistle-blowers who help unearth cases of spurious drugs.
Read More